Date and time: Tuesday 12th May 2026 at 2pm – 3pm
Traditional IVDs provide high-quality diagnostic snapshots. However, healthcare delivery is increasingly moving toward continuous, remote, and prevention-driven models.
This session explores how longitudinal wearable data and digital biomarkers may complement in vitro diagnostics, and what this shift means for product design, clinical evidence, regulatory pathways, and NHS integration. This is a strategic industry discussion — not a product session — aimed at helping IVD leaders prepare for the next evolution of diagnostics.
By the end of the session, attendees will:
1. Understand the shift from episodic testing to continuous health monitoring
2. Explore how wearable-derived data can complement IVD outputs
3. Identify regulatory and evidence implications of hybrid diagnostic models
4. Gain strategic insights into how diagnostics companies can prepare for 2030.
You can find out more and register here.
